Rhythm Biosciences announced that the latest group to join Rhythm's ColoSTAT® clinical trial is Sonic Clinical Services' Independent Practitioner Network (IPN) Medical Centres. IPN Medical Centres form part of the primary care division of Sonic Healthcare, with more than 2,000 doctors across 160 medical centres nationally. IPN provides more than 10 million patient consultations every year.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.082 AUD | 0.00% | -2.38% | -39.26% |
24/04 | Rhythm Biosciences Appoints CEO; Shares Down 3% | MT |
21/03 | Rhythm Biosciences Receives AU$2.5 Million Under Rights Issue; Shares Up 3% | MT |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-39.26% | 13.19M | |
-16.10% | 11.13B | |
+67.65% | 3.6B | |
-30.20% | 2.26B | |
-14.31% | 2.16B | |
-26.03% | 1.54B | |
+36.95% | 1.17B | |
-2.40% | 744M | |
-38.57% | 432M | |
+13.72% | 357M |
- Stock Market
- Equities
- RHY Stock
- News Rhythm Biosciences Limited
- Rhythm Biosciences Adds Sonic Clinical Services to Colostat Clinical Trial